Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeHealth

      Health

      Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026
      Health

      Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026

      October 27, 2026
      Immuron continued quarterly sales growth
      Health

      Immuron continued quarterly sales growth

      October 27, 2026
      ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026
      Health

      ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026

      October 27, 2026
      Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories
      Health

      Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories

      October 27, 2026
      Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
      Health

      Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance

      October 27, 2026
      Phathom Pharmaceuticals Provides Update on FDA Litigation
      Health

      Phathom Pharmaceuticals Provides Update on FDA Litigation

      October 26, 2026
      ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
      Health

      ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026

      October 26, 2026
      Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
      Health

      Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer

      October 26, 2026
      Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
      Health

      Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)

      October 25, 2026
      Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026
      Health

      Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

      October 24, 2026
      1 2 3 … 221 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026